Previous reports indicate that approximately 40–80% of patients with AD carry at least one copy of APOE4 [28, 30], suggesting that these patients may be at the lower end of representation in our study, compared with naturalistic samples or other clinical trials. The gene discussed is APOE; the disease is Alzheimer disease.